Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia

Steven M. Zeitels, Lee M Akst, James A. Burns, Robert E. Hillman, Matthew S. Broadhurst, R. Rox Anderson

Research output: Contribution to journalArticle

Abstract

Objectives: Treatment of glottal papillomatosis and dysplasia was mirror-guided and done in surgeons' offices in the 19th century. It migrated to the operating room in the 20th century to accommodate direct laryngoscopic surgery, which required assistants to administer anesthesia and procedural support. The primary treatment goals, which are disease regression and voice restoration and/or maintenance, are tempered by the morbidity of general anesthesia and potential treatment-induced vocal deterioration. To obviate general anesthesia, office-based laser laryngeal surgery was first done in 2001 with the 585-nm pulsed dye laser (PDL), because it employs a fiber delivery system and its energy is selectively absorbed by oxyhemoglobin. Since then, this new angiolytic laser treatment paradigm has become a mainstay of management for many surgeons; however, there are a number of shortcomings of the PDL. To further develop this concept and address the limitations of the PDL, we used a 532-nm pulsed potassium titanyl phosphate (KTP) laser. Methods: A prospective assessment was performed on 48 patients in 72 cases of recurrent glottal dysplasia (36) or papillomatosis (36). All individuals had previously undergone microlaryngoscopic management with histopathologic evaluation. Results: Two dysplasia patients did not tolerate the procedure. Of the treatable dysplasia cases, there was follow-up in 29 of 34. Disease regression was at least 75% in 18 of 29 cases (62%), 50% to 75% in 7 of 29 (24%), and 25% to 50% in the remaining 4 of 29 (14%). Papilloma patients returned for treatment when symptoms recurred, so disease regression could not be assessed accurately. Similar to data obtained with the PDL, these data confirmed that dysplastic mucosa could normalize without resection. Conclusions: Our observations revealed that the 532-nm pulsed KTP laser provided enhanced performance over the PDL laser in a number of ways. The ability to use smaller glass fibers precluded mechanical trauma to the channels of the flexible laryngoscopes and allowed for improved suctioning of secretions. Oxyhemoglobin absorbs energy better at 532 nm than at 585 nm, and the KTP laser can be delivered through a longer pulse width, These factors provide enhanced hemostasis and improved intralesional energy absorbance. Finally, unlike the PDL, the KTP laser is a solid-state laser and is not prone to mechanical failure.

Original languageEnglish (US)
Pages (from-to)679-685
Number of pages7
JournalAnnals of Otology, Rhinology and Laryngology
Volume115
Issue number9 I
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Dye Lasers
Solid-State Lasers
Papilloma
Lasers
Oxyhemoglobins
General Anesthesia
Therapeutics
Laryngoscopes
Laryngoscopy
Laser Therapy
Operating Rooms
Hemostasis
Mucous Membrane
Anesthesia
Maintenance
Morbidity
Wounds and Injuries

Keywords

  • Dysphonia
  • Dysplasia
  • Glottis
  • Hoarseness
  • Keratosis
  • KTP laser
  • Laryngoscopy
  • Papillomatosis
  • Vocal cord
  • Vocal fold

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Zeitels, S. M., Akst, L. M., Burns, J. A., Hillman, R. E., Broadhurst, M. S., & Anderson, R. R. (2006). Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Annals of Otology, Rhinology and Laryngology, 115(9 I), 679-685.

Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. / Zeitels, Steven M.; Akst, Lee M; Burns, James A.; Hillman, Robert E.; Broadhurst, Matthew S.; Anderson, R. Rox.

In: Annals of Otology, Rhinology and Laryngology, Vol. 115, No. 9 I, 09.2006, p. 679-685.

Research output: Contribution to journalArticle

Zeitels, SM, Akst, LM, Burns, JA, Hillman, RE, Broadhurst, MS & Anderson, RR 2006, 'Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia', Annals of Otology, Rhinology and Laryngology, vol. 115, no. 9 I, pp. 679-685.
Zeitels, Steven M. ; Akst, Lee M ; Burns, James A. ; Hillman, Robert E. ; Broadhurst, Matthew S. ; Anderson, R. Rox. / Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. In: Annals of Otology, Rhinology and Laryngology. 2006 ; Vol. 115, No. 9 I. pp. 679-685.
@article{c51ac69cfd2a4ae298037ee2c4d7b0f7,
title = "Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia",
abstract = "Objectives: Treatment of glottal papillomatosis and dysplasia was mirror-guided and done in surgeons' offices in the 19th century. It migrated to the operating room in the 20th century to accommodate direct laryngoscopic surgery, which required assistants to administer anesthesia and procedural support. The primary treatment goals, which are disease regression and voice restoration and/or maintenance, are tempered by the morbidity of general anesthesia and potential treatment-induced vocal deterioration. To obviate general anesthesia, office-based laser laryngeal surgery was first done in 2001 with the 585-nm pulsed dye laser (PDL), because it employs a fiber delivery system and its energy is selectively absorbed by oxyhemoglobin. Since then, this new angiolytic laser treatment paradigm has become a mainstay of management for many surgeons; however, there are a number of shortcomings of the PDL. To further develop this concept and address the limitations of the PDL, we used a 532-nm pulsed potassium titanyl phosphate (KTP) laser. Methods: A prospective assessment was performed on 48 patients in 72 cases of recurrent glottal dysplasia (36) or papillomatosis (36). All individuals had previously undergone microlaryngoscopic management with histopathologic evaluation. Results: Two dysplasia patients did not tolerate the procedure. Of the treatable dysplasia cases, there was follow-up in 29 of 34. Disease regression was at least 75{\%} in 18 of 29 cases (62{\%}), 50{\%} to 75{\%} in 7 of 29 (24{\%}), and 25{\%} to 50{\%} in the remaining 4 of 29 (14{\%}). Papilloma patients returned for treatment when symptoms recurred, so disease regression could not be assessed accurately. Similar to data obtained with the PDL, these data confirmed that dysplastic mucosa could normalize without resection. Conclusions: Our observations revealed that the 532-nm pulsed KTP laser provided enhanced performance over the PDL laser in a number of ways. The ability to use smaller glass fibers precluded mechanical trauma to the channels of the flexible laryngoscopes and allowed for improved suctioning of secretions. Oxyhemoglobin absorbs energy better at 532 nm than at 585 nm, and the KTP laser can be delivered through a longer pulse width, These factors provide enhanced hemostasis and improved intralesional energy absorbance. Finally, unlike the PDL, the KTP laser is a solid-state laser and is not prone to mechanical failure.",
keywords = "Dysphonia, Dysplasia, Glottis, Hoarseness, Keratosis, KTP laser, Laryngoscopy, Papillomatosis, Vocal cord, Vocal fold",
author = "Zeitels, {Steven M.} and Akst, {Lee M} and Burns, {James A.} and Hillman, {Robert E.} and Broadhurst, {Matthew S.} and Anderson, {R. Rox}",
year = "2006",
month = "9",
language = "English (US)",
volume = "115",
pages = "679--685",
journal = "Annals of Otology, Rhinology and Laryngology",
issn = "0003-4894",
publisher = "Annals Publishing Company",
number = "9 I",

}

TY - JOUR

T1 - Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia

AU - Zeitels, Steven M.

AU - Akst, Lee M

AU - Burns, James A.

AU - Hillman, Robert E.

AU - Broadhurst, Matthew S.

AU - Anderson, R. Rox

PY - 2006/9

Y1 - 2006/9

N2 - Objectives: Treatment of glottal papillomatosis and dysplasia was mirror-guided and done in surgeons' offices in the 19th century. It migrated to the operating room in the 20th century to accommodate direct laryngoscopic surgery, which required assistants to administer anesthesia and procedural support. The primary treatment goals, which are disease regression and voice restoration and/or maintenance, are tempered by the morbidity of general anesthesia and potential treatment-induced vocal deterioration. To obviate general anesthesia, office-based laser laryngeal surgery was first done in 2001 with the 585-nm pulsed dye laser (PDL), because it employs a fiber delivery system and its energy is selectively absorbed by oxyhemoglobin. Since then, this new angiolytic laser treatment paradigm has become a mainstay of management for many surgeons; however, there are a number of shortcomings of the PDL. To further develop this concept and address the limitations of the PDL, we used a 532-nm pulsed potassium titanyl phosphate (KTP) laser. Methods: A prospective assessment was performed on 48 patients in 72 cases of recurrent glottal dysplasia (36) or papillomatosis (36). All individuals had previously undergone microlaryngoscopic management with histopathologic evaluation. Results: Two dysplasia patients did not tolerate the procedure. Of the treatable dysplasia cases, there was follow-up in 29 of 34. Disease regression was at least 75% in 18 of 29 cases (62%), 50% to 75% in 7 of 29 (24%), and 25% to 50% in the remaining 4 of 29 (14%). Papilloma patients returned for treatment when symptoms recurred, so disease regression could not be assessed accurately. Similar to data obtained with the PDL, these data confirmed that dysplastic mucosa could normalize without resection. Conclusions: Our observations revealed that the 532-nm pulsed KTP laser provided enhanced performance over the PDL laser in a number of ways. The ability to use smaller glass fibers precluded mechanical trauma to the channels of the flexible laryngoscopes and allowed for improved suctioning of secretions. Oxyhemoglobin absorbs energy better at 532 nm than at 585 nm, and the KTP laser can be delivered through a longer pulse width, These factors provide enhanced hemostasis and improved intralesional energy absorbance. Finally, unlike the PDL, the KTP laser is a solid-state laser and is not prone to mechanical failure.

AB - Objectives: Treatment of glottal papillomatosis and dysplasia was mirror-guided and done in surgeons' offices in the 19th century. It migrated to the operating room in the 20th century to accommodate direct laryngoscopic surgery, which required assistants to administer anesthesia and procedural support. The primary treatment goals, which are disease regression and voice restoration and/or maintenance, are tempered by the morbidity of general anesthesia and potential treatment-induced vocal deterioration. To obviate general anesthesia, office-based laser laryngeal surgery was first done in 2001 with the 585-nm pulsed dye laser (PDL), because it employs a fiber delivery system and its energy is selectively absorbed by oxyhemoglobin. Since then, this new angiolytic laser treatment paradigm has become a mainstay of management for many surgeons; however, there are a number of shortcomings of the PDL. To further develop this concept and address the limitations of the PDL, we used a 532-nm pulsed potassium titanyl phosphate (KTP) laser. Methods: A prospective assessment was performed on 48 patients in 72 cases of recurrent glottal dysplasia (36) or papillomatosis (36). All individuals had previously undergone microlaryngoscopic management with histopathologic evaluation. Results: Two dysplasia patients did not tolerate the procedure. Of the treatable dysplasia cases, there was follow-up in 29 of 34. Disease regression was at least 75% in 18 of 29 cases (62%), 50% to 75% in 7 of 29 (24%), and 25% to 50% in the remaining 4 of 29 (14%). Papilloma patients returned for treatment when symptoms recurred, so disease regression could not be assessed accurately. Similar to data obtained with the PDL, these data confirmed that dysplastic mucosa could normalize without resection. Conclusions: Our observations revealed that the 532-nm pulsed KTP laser provided enhanced performance over the PDL laser in a number of ways. The ability to use smaller glass fibers precluded mechanical trauma to the channels of the flexible laryngoscopes and allowed for improved suctioning of secretions. Oxyhemoglobin absorbs energy better at 532 nm than at 585 nm, and the KTP laser can be delivered through a longer pulse width, These factors provide enhanced hemostasis and improved intralesional energy absorbance. Finally, unlike the PDL, the KTP laser is a solid-state laser and is not prone to mechanical failure.

KW - Dysphonia

KW - Dysplasia

KW - Glottis

KW - Hoarseness

KW - Keratosis

KW - KTP laser

KW - Laryngoscopy

KW - Papillomatosis

KW - Vocal cord

KW - Vocal fold

UR - http://www.scopus.com/inward/record.url?scp=33748996212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748996212&partnerID=8YFLogxK

M3 - Article

C2 - 17044539

AN - SCOPUS:33748996212

VL - 115

SP - 679

EP - 685

JO - Annals of Otology, Rhinology and Laryngology

JF - Annals of Otology, Rhinology and Laryngology

SN - 0003-4894

IS - 9 I

ER -